Journal profile

Journal of aerosol medicine and pulmonary drug delivery

Publisher: SAGE Publications
ISSN1941-2711 | 1941-2703 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
2.98
Citation rate 2.16 169 total citations
h5-index 19 h5 depth signal
Cited share 63.8% 51 of 80
Total citations 169 Citation footprint
Metric signal 2.88 External metric anchor
Self-citation 3.0% 5 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 192
United Kingdom 49
Canada 40
Germany 36
China 28

Citing Fields of Research

Drug Delivery Systems 247
Respiratory Support 179
Allergies 113
Cystic Fibrosis 35
Pharmacology & Toxicology 23

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 851 Articles tracked across the journal lifetime
Indexed publication set 80 51 cited publications
Last 12 months 45 3.8 publications/month
Open access share 6.7% 3 OA publications in the last year
Leading citing country United States 192 citing publications
Leading citing field Drug Delivery Systems 247 citing publications
Latest tracked publication 30 September 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v21n1, 2008-
PubMed
v21n1, 2008-

Research Focus & Classification

Indexed Subjects

Drug Delivery Systems Respiratory Support Allergies

Issuing & Sponsoring Bodies

Contributor
International Society for Aerosols in Medicine

Broad Categories

Drug Therapy Pulmonary Medicine Drug Delivery Systems

MeSH Descriptors

Aerosols Drug Delivery Systems Inhalation Exposure Lung Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Benjamin Heine, Uwe Schuschnig, Jakob Richter et al.
Background: Efficient aerosol therapy depends on both device performance and inhalation technique. Breath-triggered vibrating mesh nebulizers reduce drug loss by generating aerosol only during inspiration but may prolong treatment. Guidi...
08
Angelo Matturro, Navid Monshi Tousi, Hosein Sadafi et al.
Pressurized metered-dose inhalers (pMDIs) rely on hydrofluoroalkane (HFA) propellants that have a high global warming potential (GWP). Reformulation with next-generation, low-GWP propellants, such as HFA-152a, offers a strategy to reduce...
09
Scott H. Donaldson, Kirby L. Zeman, Alan Bell et al.
Background: Pressurized metered-dose inhalers (pMDIs) are commonly used for respiratory disease treatment but contain propellants, such as hydrofluoroalkane-134a (HFA-134a), with global warming potential (GWP) that contribute to the clim...

Bibliographical & Catalog Notes

Description based on first issue; title from cover.

Also issued online.